Pierre Van Damme

Papers

Total Citations

H-Index

About

Pierre Van Damme is a leading epidemiologist and vaccinologist whose research has profoundly shaped global public health policy, particularly in the prevention of infectious diseases through vaccination. His key research areas include human papillomavirus (HPV) epidemiology, vaccine safety, and the immunogenicity of hepatitis B and other viral vaccines. Van Damme’s major contributions include pioneering work on HPV DNA detection in women, as exemplified by his study on anal HPV DNA in colposcopy clinic patients (2012, 14 citations), which advanced understanding of HPV transmission and cancer risk. He is also renowned for his leadership in large-scale vaccine trials, including those for hepatitis B and COVID-19, and for his role in establishing the European Centre for Disease Prevention and Control’s vaccine advisory board. With over 600 publications and a citation count exceeding 30,000, Van Damme’s impact is immense. Notably, he served as principal investigator for the pivotal clinical trials of the hepatitis B vaccine in infants and contributed to the development of the HPV vaccine schedule. His work has been instrumental in reducing vaccine-preventable disease burdens worldwide, making him a trusted voice in vaccinology and a mentor to a generation of public health researchers.